Here's What the Street Thinks About Elanco Animal Health Incorporated (ELAN)

Elanco Animal Health Incorporated (NYSE:ELAN) is one of the best healthcare stocks under $50 to invest in. Elanco Animal Health Incorporated (NYSE:ELAN) received several rating updates in January, with BofA most recently adjusting the price target on the stock to $28 from $25 on January 30 and maintaining a Buy rating. The firm lifted its price target going into the fiscal Q4 earnings season, telling investors that it did so to reflect stronger operational results and execution. UBS also raised the price target on Elanco Animal Health Incorporated (NYSE:ELAN) to $30 from $27 on January 29, reaffirming a Buy rating.

In addition, Piper Sandler upgraded Elanco Animal Health Incorporated (NYSE:ELAN) to Overweight from Neutral on January 22. The firm raised the price target to $30 from $24, telling investors after attending the VMX conference that the company “is making some serious inroads” with corporate groups. It believes that the corporate channel reflects a new driver for the company, and added that it found little push back to the idea that Elanco Animal Health Incorporated (NYSE:ELAN) will raise prices on its core franchise.

Elanco Animal Health Incorporated (NYSE:ELAN) is an animal health company that delivers services and products that prevent and treat disease in pets and farm animals. Its diverse portfolio serves animals across various species, primarily cats, dogs, cattle, swine, poultry, and sheep.

While we acknowledge the potential of ELAN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.